Quest Partners LLC Pliant Therapeutics, Inc. Transaction History
Quest Partners LLC
- $753 Billion
- Q4 2024
A detailed history of Quest Partners LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 6,681 shares of PLRX stock, worth $52,044. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,681
Previous 25,571
73.87%
Holding current value
$52,044
Previous $287 Million
69.3%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
63.3MCall Options Held
245KPut Options Held
373K-
Deep Track Capital, LP Greenwich, CT5.97MShares$46.5 Million2.47% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$38.7 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.83MShares$37.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$27.5 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$24.9 Million2.34% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $379M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...